RxSight discloses CFO's sign-on bonus of $169K and corrects option vesting schedule

RxSight, Inc.

CFO Mark Wilterding's sign-on bonus determined at $169,348.10 and paid March 13, 2026.
Sign-on bonus paid less payroll deductions and required withholding, per employment letter.
Option vesting corrected: 25% vests on Jan 11, 2027 anniversary, balance monthly over next 3 years.
Option fully vested after 4 years from Jan 11, 2026, subject to continued employment.
Amendment filed to prior 8-K dated Jan 12, 2026 regarding CFO appointment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.